Europe Radioactive Tracer Market Forecast to 2030

Europe Radioactive Tracer Market Forecast to 2030 – Regional Analysis – by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)

Send Enquiry
Item ID: BMIRE00029114 Category: Tags: , ,

$2,485$3,885

Description

The Europe radioactive tracer market was valued at US$ 4,175.25 million in 2022 and is expected to reach US$ 16,098.93 million by 2030; it is estimated to grow at a CAGR of 18.4% from 2022 to 2030.

Use of Radioactive Tracer in Cancer Diagnosis fuel the Europe Radioactive Tracer Market

Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient’s body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.

Europe Radioactive Tracer Market Overview

The Europe radioactive tracer market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with such as rising prevalence of neurologic disorders such as, Alzheimer’s and others along with the developments made by the players operating in the region.

Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

Europe Radioactive Tracer Market Segmentation

The Europe radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Europe radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the Europe radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the Europe radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the Europe radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the Europe radioactive tracer market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, ABX advanced biochemical compounds GmbH, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading companies operating in the Europe radioactive tracer market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 18.4% CAGR, the Europe Radioactive Tracer Market is Speculated to be worth US$ 16,098.93 million by 2030, saysthe research team

According tothe research team’ research,, the Europe radioactive tracer market was valued at US$ 4,175.25 million in 2022 and is expected to reach US$ 16,098.93 million by 2030, registering a CAGR of 18.4% from 2022 to 2030. Rising prevalence of chronic diseases and increasing use of nuclear imaging techniques are the critical factors attributed to the Europe radioactive tracer market expansion.

The European Union Committee has taken various initiatives to boost R&D activities in the field of radioactive tracer and radioisotopes. The Isotope Production and Distribution Program (IPDP) was established within the DOE’s Office of Nuclear Energy to enhance the production and marketing of DOE-produced isotopes for research and commercial purposes. The IPDP was established on a condition that its operations were to be financially self-supporting.

PRISMAP is a European medical radionuclide program that was started to provide access to novel radioisotopes of high purity grade for medical research. According to the data provided under this program, out of the ~3,000 different radioisotopes synthesized by scientists in laboratories under European Union, only a handful are used regularly for medical procedures, mostly for imaging. Such a rise in the number of initiatives for boosting the supply of radioactive tracer for research purposes, which is expected to fuel the growth of the radioactive tracer market. Many hospitals and research institutes focus on developing and using different radioactive tracer to diagnose chronic diseases.

On the contrary, short shelf-life of radioactive tracer hurdles the growth of Europe radioactive tracer market.

Based on tracer type, the Europe radioactive tracer market is categorized into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held 66.0% market share in 2022, amassing US$ 2,755.25 million. It is projected to garner US$ 10,610.02 million by 2030 to expand at 18.4% CAGR during 2022–2030.

Based on test type, the Europe radioactive tracer market is categorized into PET, SPECT, and others. The SPECT segment held 44.7% share of Europe radioactive tracer market in 2022, amassing US$ 1,866.36 million. It is projected to garner US$ 7,170.37 million by 2030 to expand at 18.3% CAGR during 2022–2030.

Based on end user, the Europe radioactive tracer market is categorized into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held 70.0% share of Europe radioactive tracer market in 2022, amassing US$ 2,923.03 million. It is projected to garner US$ 11,260.14 million by 2030 to expand at 18.4% CAGR during 2022–2030.

Based on application, the Europe radioactive tracer market is categorized into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held 62.7% share of Europe radioactive tracer market in 2022, amassing US$ 2,618.67 million. It is projected to garner US$ 9,828.90 million by 2030 to expand at 18.0% CAGR during 2022–2030.

Based on country, the Europe radioactive tracer market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 30.2% share of Europe radioactive tracer market in 2022. It was assessed at US$ 1,261.34 million in 2022 and is likely to hit US$ 4,850.61 million by 2030, exhibiting a CAGR of 18.3% during 2022–2030.

Key players operating in the Europe radioactive tracer market are Rotem Industries Ltd, ABX advanced biochemical compounds GmbH, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions, among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Radioactive Tracer Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
4.2.1 Short Shelf-Life of Radioactive Tracer
4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
4.3.1 New Initiatives for Radioactive Tracer R&D
4.4 Future Trends
4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:
5. Radioactive Tracer Market – Europe Market Analysis
5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
6. Europe Radioactive Tracer Market – Revenue and Forecast to 2030 – by Tracer Types
6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
6.3.1 Overview
6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine 131
6.4.1 Overview
6.4.2 Iodine 131: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Iron 59
6.5.1 Overview
6.5.2 Iron 59: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium- 171
6.6.1 Overview
6.6.2 Lutetium- 171: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
6.7.1 Overview
6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium 46
6.8.1 Overview
6.8.2 Scandium 46: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
6.9.1 Overview
6.9.2 Seaborgium-269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
6.10.1 Overview
6.10.2 Hassium -269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA 67
6.11.1 Overview
6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
6.12.1 Overview
6.12.2 PSMA GA68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
6.13.1 Overview
6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
6.14.1 Overview
6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
6.15.1 Overview
6.15.2 Thallium-201: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
6.16.1 Overview
6.16.2 F-18 FDG: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
6.17.1 Overview
6.17.2 F-18 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
6.18.1 Overview
6.18.2 GA 68 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
6.19.1 Overview
6.19.2 F-18 PSMA: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
6.20.1 Overview
6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.21 Others
6.21.1 Overview
6.21.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Radioactive Tracer Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
7.3.1 Overview
7.3.2 PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
7.4.1 Overview
7.4.2 SPECT: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Radioactive Tracer Market – Revenue and Forecast to 2030 – by Application.
8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
8.4.1 Overview
8.4.2 Pulmonary: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Radioactive Tracer Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Radioactive Tracer Market – Country Analysis
10.1 Europe Radioactive Tracer Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Europe Radioactive Tracer Market by Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.1.2 Germany Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Germany Radioactive Tracer Market, by Tracer Types
10.1.2.1.4 Germany Radioactive Tracer Market, by Test Type
10.1.2.1.5 Germany Radioactive Tracer Market, by Application
10.1.2.1.6 Germany Radioactive Tracer Market, by End-User
10.1.2.2 UK
10.1.2.2.1 Overview
10.1.2.2.2 UK Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 UK Radioactive Tracer Market, by Tracer Types
10.1.2.2.4 UK Radioactive Tracer Market, by Test Type
10.1.2.2.5 UK Radioactive Tracer Market, by Application
10.1.2.2.6 UK Radioactive Tracer Market, by End-User
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 France Radioactive Tracer Market, by Tracer Types
10.1.2.3.4 France Radioactive Tracer Market, by Test Type
10.1.2.3.5 France Radioactive Tracer Market, by Application
10.1.2.3.6 France Radioactive Tracer Market, by End-User
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.3 Italy Radioactive Tracer Market, by Tracer Types
10.1.2.4.4 Italy Radioactive Tracer Market, by Test Type
10.1.2.4.5 Italy Radioactive Tracer Market, by Application
10.1.2.4.6 Italy Radioactive Tracer Market, by End-User
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 Spain Radioactive Tracer Market, by Tracer Types
10.1.2.5.4 Spain Radioactive Tracer Market, by Test Type
10.1.2.5.5 Spain Radioactive Tracer Market, by Application
10.1.2.5.6 Spain Radioactive Tracer Market, by End-User
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Europe Radioactive Tracer Market, by Tracer Types
10.1.2.6.4 Rest of Europe Radioactive Tracer Market, by Test Type
10.1.2.6.5 Rest of Europe Radioactive Tracer Market, by Application
10.1.2.6.6 Rest of Europe Radioactive Tracer Market, by End-User
11. Radioactive Tracer Market Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Radioactive Tracer Market, Key Company Profiles
12.1 Rotem Industries Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ABX advanced biochemical compounds GmbH
12.2.1 Business Description
12.2.2 Products and Services
12.2.3 Financial Overview
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.3 Invicro LLC
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cardinal Health Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Newcastle University
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Curium
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Blue Earth Diagnostics Limited
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 General Electric Co
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 IBA Radiopharma Solutions
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Radioactive Tracer Market Segmentation
Table 2. Principal Radionuclides Used in Radioactive Tracer
Table 3. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 4. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 5. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 6. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 7. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 8. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 9. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 10. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 11. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 12. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 13. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 14. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 15. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 16. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 17. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 18. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 19. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 20. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 21. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 22. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 23. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 24. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 25. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 26. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 27. Organic Developments Done by Companies
Table 28. Inorganic Developments Done by Companies
Table 29. Glossary of Terms, Europe Radioactive Tracer Market

LIST OF FIGURES

Figure 1. Europe Radioactive Tracer Market Segmentation, By Country
Figure 2. Europe Radioactive Tracer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
Figure 6. Technetium 99m and TC-97m: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Iodine 131: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Iron 59: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Lutetium- 171: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. RB82 and ammonia N-13: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Scandium 46: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Seaborgium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Hassium -269: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Gallium Citrate GA 67: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. PSMA GA68: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. FDDNP (F-18) and FDOPA (f-18): Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Phosphorus 32 and Chromium -51: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Thallium-201: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. F-18 FDG: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. F-18 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. GA 68 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. F-18 PSMA: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 26. PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
Figure 30. Oncology: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pulmonary: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Neurology: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Cardiology: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Europe Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
Figure 36. Hospitals and Clinics: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diagnostic Centers: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Academic and Research Institutes: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Europe Radioactive Tracer Market, By Country, 2022 ($Mn)
Figure 41. Europe Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
Figure 42. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 45. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 47. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)

The List of Companies – Europe Radioactive Tracer Market

– Rotem Industries Ltd
– ABX advanced biochemical compounds GmbH
– Invicro LLC
– Cardinal Health Inc
– Newcastle University
– Novartis AG
– Curium
– Blue Earth Diagnostics Limited
– General Electric Co
– IBA Radiopharma Solutions

Reviews

There are no reviews yet.

Be the first to review “Europe Radioactive Tracer Market Forecast to 2030”